UK markets close in 7 hours 28 minutes

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.1600-0.0900 (-2.12%)
At close: 04:00PM EDT
4.0700 -0.09 (-2.16%)
After hours: 06:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 245.60M
Enterprise value 118.43M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.05
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.36

Trading information

Stock price history

Beta (5Y monthly) 1.52
52-week change 3-60.34%
S&P500 52-week change 321.83%
52-week high 311.9700
52-week low 31.4200
50-day moving average 33.5244
200-day moving average 34.6251

Share statistics

Avg vol (3-month) 3587.58k
Avg vol (10-day) 31.18M
Shares outstanding 558.9M
Implied shares outstanding 658.9M
Float 842.66M
% held by insiders 12.01%
% held by institutions 162.34%
Shares short (28 Mar 2024) 42.05M
Short ratio (28 Mar 2024) 43.86
Short % of float (28 Mar 2024) 44.42%
Short % of shares outstanding (28 Mar 2024) 43.48%
Shares short (prior month 29 Feb 2024) 41.94M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-16.23%
Return on equity (ttm)-27.73%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -42.53M
Net income avi to common (ttm)-37.54M
Diluted EPS (ttm)-0.6400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)142.82M
Total cash per share (mrq)2.42
Total debt (mrq)15.66M
Total debt/equity (mrq)13.07%
Current ratio (mrq)6.64
Book value per share (mrq)2.02

Cash flow statement

Operating cash flow (ttm)-30.33M
Levered free cash flow (ttm)-27.62M